Forge makes the Starbucks loyalty app for hundreds of restaurants like Chubby Group, Rooster & Rice, and Liuyishou Hotpot. 3 months free – before NRA! Email: ethan@forgerewards.com
Eden
With over 1 billion medical images processed annually, Eden leads the world in cloud-based RIS/PACS solutions.
Eddie AI
Eddie is the AI assistant video editor for prosâcrafting story-driven rough cuts from raw footage, fast. [ We’re launching something new at NAB. Meet us to see whatâs nextâand how to add an AI AE to your workflow.]The agentic editor Eddie (aka “ChatGPT for video editing”) is built for post-production workflows. Eddie seamlessly handles multicams and pro codecs (Sony, BRAW, R3D, Canon, and more) and integrates directly with Adobe Premiere Pro, DaVinci Resolve, and Final Cut Pro.Eddie is your AI AE. And it takes on the most time-consuming parts of the edit:logs interviews and B-roll (demo), organizing footage into structured bins and sequences.builds docu-style edits from interviews (demo)âselecting soundbites, shaping narrative, and placing relevant B-roll over the story.creates stringouts, testimonials, and social cuts from your prompts.cuts scripted content (demo)âcollating takes, selecting the best one, and assembling to script.edits multicam podcasts (up to 6 cameras), choosing the right angle at the right moment.The output is a fully editable timeline, returned to your NLE for finishing, polish, and color.Eddie brings timeline intelligence into post-productionâhelping editors move from raw footage to rough cut in a fraction of the time.Meet with us to learn more.
Dossier, Inc.
Dossier is a cloud-based, competency management software that makes implementing, tracking, and monitoring thousands of competencies across healthcare staff, departments, facilities, and the full learning system effortless. 500,000+ healthcare staff have ended the paper chase and are now One Step Ahead with Dossier.
DELFI Diagnostics
DELFI Diagnostics is developing next-generation, blood-based tests that are accurate, accessible and deliver a new way to help detect cancer. Employing advanced machine-learning methods to whole-genome sequencing data, the DELFI platform is built to address the highest-burden health challenges. We prioritize solutions that have the potential to save lives on a global scale, including for historically underserved populations. DELFI’s platform relies on fragmentomics – the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments. FirstLook Lung, for individuals eligible for lung cancer screening, is our first laboratory-developed screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early stage disease, with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA. For more information, visit www.delfidiagnostics.com. | DELFI Diagnostics is developing next-generation, blood-based tests that are accurate, accessible, and deliver a new way to help detect cancer. DELFI tests are built to solve the highest-burden population health issues, including in historically underserved demographics, and have the potential to save lives on a global scale. FirstLook Lung, for individuals eligible for lung cancer screening, is our first laboratory-developed screening test and requires a simple blood draw that can be incorporated with routine blood work. The test is based on fragmentomics, the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments in the blood. The DELFI platform applies advanced machine-learning technology to whole-genome sequencing data to assess individuals’ cfDNA fragments against populations with and without cancer. FirstLook Lung uses these millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early-stage disease, with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA. To learn more about the FirstLook Lung test, visit www.delfidiagnostics.com or www.firstlooktest.com.
D-Wave Quantum
D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. Our mission is to help customers realize the value of quantum, today. Our customers are using our powerful technology to solve problems in diverse sectors such as manufacturing, logistics, life sciences, financial services and more.
Cystic Fibrosis Research Institute
Founded in 1975, Cystic Fibrosis Research Institute (CFRI) seeks to be a global resource for the cystic fibrosis community while pursuing a cure through research, education, advocacy, and support. We serve those living with or affected by cystic fibrosis (CF), a life-shortening, progressive genetic disease known for its respiratory impacts but which impacts all major organs. CFRI provides cystic fibrosis scientific research grants through two programs. The New Horizons Program funds principal investigators (PI) at medical and academic institutions across the nation for two-year projects. The program endeavors to fund those applications with the greatest relevance to finding improved treatments or a cure for CF. The Elizabeth Nash Fellowship Program funds post-doctoral fellows nationwide for two-year projects, and encourage collaborative research and communication between the institutions and PI’s. Through its Patrick Nash CF Fellows Training Program, CFRI seeks to develop a multidisciplinary model of care for adults with CF. Selected fellows representing a wide range of medical disciplines participate in an annual symposium, quarterly meetings to encourage collaborative research, and work with expert mentors. Applications for the 2025 program are available March 1 through May 31. In addition to supporting CF research, CFRI provides educational, psychosocial, and advocacy programs and services to those with CF and their families, caregivers, and healthcare professionals. Living with CF is challenging physically, emotionally and financially. We provide resources that address the multi-faceted needs of the CF community while increasing awareness of CF through outreach and advocacy activities.
Cut+Dry
Cut+Dry is the top digital platform for Foodservice Distributors. Using powerful, simple and intuitive technology to make food commerce a more enjoyable, profitable,and less wasteful experience. Our secret sauce is connecting manufacturers, distributors, and restaurants through technology and data, and working together to change food service.